Publications
- ABL1, SRC and other non-receptor tyrosine-kinases as new targets for specific anticancer therapy2010 | First Faculty of Medicine
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | First Faculty of Medicine, Third Faculty of Medicine
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | First Faculty of Medicine, Second Faculty of Medicine
- Cell-specific modulation of mitochondrial respiration and metabolism by the pro-apoptotic Bcl-2 family members Bax and Bak2023 | First Faculty of Medicine, Faculty of Science
- Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping2023 | First Faculty of Medicine
- Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma2023 | First Faculty of Medicine
- BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis2023 | First Faculty of Medicine
- Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
Loading network view...